Fol. Biol. 2023, 69, 107-115
https://doi.org/10.14712/fb2023069040107
Germline Pathogenic Variants in Squamous Cell Carcinoma of the Head and Neck
References
1. , M. (2021) Bloom syndrome and the underlying causes of genetic instability. Mol. Genet. Metab. 133, 35-48.
<https://doi.org/10.1016/j.ymgme.2021.03.003>
2. , D., Lin, J. C., Sacco, A. G. et al. (2019) Palbociclib plus cetuximab versus placebo plus cetuximab in platinum-resistant, cetuximab-naive, HPV-unrelated head and neck cancer: a double-blind randomized phase II trial (PALATINUS). J. Clin. Oncol. 37(Suppl 15), 6013.
<https://doi.org/10.1200/JCO.2019.37.15_suppl.6013>
3. , M. M. (2020) Dyskeratosis congenita: a literature review. J. Dtsch. Dermatol. Ges. 18, 943-967.
4. , E. R., Mangat, P. K., Garrett-Mayer, E. et al. (2020) Palbociclib in patients with non-small-cell lung cancer with CDKN2A alterations: results from the targeted agent and profiling utilization registry study. JCO Precis. Oncol. 4, 757-766.
<https://doi.org/10.1200/PO.20.00037>
5. , B. P., Giri, N., Savage, S. A. et al. (2009) Cancer in dyskeratosis congenita. Blood 113, 6549-6557.
<https://doi.org/10.1182/blood-2008-12-192880>
6. , B. P. (2014) Fanconi anemia and the development of leukemia. Best Pract. Res. Clin. Haematol. 27, 214-221.
<https://doi.org/10.1016/j.beha.2014.10.002>
7. , K. K., Harris, J., Wheeler, R. et al. (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24-35.
<https://doi.org/10.1056/NEJMoa0912217>
8. , S., Křížová, Ľ., Matějů, M. et al. (2023) Radiation-induced lymphopoenia and treatment outcome in hereditary breast cancer patients. Folia Biol. (Praha) 69, 91-98.
<https://doi.org/10.14712/fb2023069030091>
9. , H., Chacon, A. H., Choudhary, S. et al. (2014) Bloom syndrome. Int. J. Dermatol. 53, 798-802.
<https://doi.org/10.1111/ijd.12408>
10. , C., Atcı, T., Yılmaz, Z. et al. (2021) Skin tumors in xeroderma pigmentosum: evaluation of a large series and a literature review. J. Cutan. Pathol. 48, 884-895.
<https://doi.org/10.1111/cup.13979>
11. , A. S., Biller, H. F. (1988) Head and neck cancer associated with Bloom’s syndrome. Laryngoscope 98, 746-748.
<https://doi.org/10.1288/00005537-198807000-00012>
12. , F. B., Barros Filho, M. C., Kuasne, H. et al. (2015) PHF21B as a candidate tumour suppressor gene in head and neck squamous cell carcinomas. Mol. Oncol. 9, 450-462.
<https://doi.org/10.1016/j.molonc.2014.09.009>
13. , A. C., Uhlmann,W. R., Brenner, J. C. et al. (2016) Getting personal: head and neck cancer management in the era of genomic medicine. Head Neck 38, E2250-E2258.
<https://doi.org/10.1002/hed.24132>
14. , V., Braakhuis, B. J., Tobi, H. et al. (1996) The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer. Cancer Epidemiol. Biomarkers Prev. 5, 595-598.
15. , D. A., Idler, B. M., Kunze, K. L. et al. (2023) Germline genetic testing in unselected squamous and non-squamous head and neck cancers. Laryngoscope 133, 3378-3388.
<https://doi.org/10.1002/lary.30720>
16. , B. L., Li, T., Sotelo, J. et al. (2022) Identification and management of pathogenic variants in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program. Clin. Cancer Res. 28, 2349-2360.
<https://doi.org/10.1158/1078-0432.CCR-21-2861>
17. , A., Burnichon, N., Favier, J. et al. (2020) An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract. Res. Clin. Endocrinol. Metab. 34, 101416.
<https://doi.org/10.1016/j.beem.2020.101416>
18. , R., Astudillo, A., Valle, M. et al. (2013) Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas. Head Neck 35, E80-E84.
<https://doi.org/10.1002/hed.21911>
19. (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576-582.
<https://doi.org/10.1038/nature14129>
20. , M. C., Kimura, T. C., Tolentino, E. S. et al. (2020) Unusual intraoral cancer with unexpected outcome in a patient with xeroderma pigmentosum: an alert for antineoplastic treatment. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 129, e1-e11.
<https://doi.org/10.1016/j.oooo.2019.09.017>
21. , S. H., Chiang, J., Ngeow, J. (2021) CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition. Hered. Cancer Clin. Pract. 19, 21.
<https://doi.org/10.1186/s13053-021-00178-x>
22. , S. C., Chinn, S. B., Donovan, F. X. et al. (2017) Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50. Cancer 123, 3943-3954.
<https://doi.org/10.1002/cncr.30802>
23. , R., Zhang, J., Nepal, M. et al. (2017) Multifaceted Fanconi anemia signaling. Trends Genet. 34, 171-183.
<https://doi.org/10.1016/j.tig.2017.11.006>
24. , Y. P., Chan, A. T. C., Le, Q. T. et al. (2019) Nasopharyngeal carcinoma. Lancet 394, 64-80.
<https://doi.org/10.1016/S0140-6736(19)30956-0>
25. , R. D. (2012) Morphologic features of conventional squamous cell carcinoma of the oropharynx: ‘keratinizing’ and ‘nonkeratinizing’ histologic types as the basis for a consistent classification system. Head Neck Pathol. 6 (Suppl 1), S41-S47.
<https://doi.org/10.1007/s12105-012-0373-4>
26. , E. B. (1995) The genetic epidemiology of cancer. Cancer Surv. 25, 13-26.
27. , S. S., Miranda, P. M., Marchi, F. A. et al. (2021) Germline variants in DNA repair genes are associated with young-onset head and neck cancer. Oral Oncol. 122, 105545.
<https://doi.org/10.1016/j.oraloncology.2021.105545>
28. , L., Torelli, N., Biancotto, E. et al. (2016) Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models. Eur. J. Epidemiol. 31, 385-393.
<https://doi.org/10.1007/s10654-015-0028-3>
29. , J., Mateo, J., Fizazi, K. et al. (2020) Olaparib for metastatic castration-resistant prostate cancer. N. Engl. J. Med. 382, 2091-2102.
<https://doi.org/10.1056/NEJMoa1911440>
30. , C. (2017) How I manage patients with Fanconi anemia. Br. J. Haematol. 178, 32-47.
<https://doi.org/10.1111/bjh.14615>
31. , C., Pierri, F. (2022) Modern management of Fanconi anemia. Hematology Am. Soc. Hematol. Educ. Program 1, 649-657.
<https://doi.org/10.1182/hematology.2022000393>
32. , C., Westra, W. H., Li, S. et al. (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl. Cancer Inst. 100, 261-269.
<https://doi.org/10.1093/jnci/djn011>
33. , F., Koutsodontis, G., Vagia, E. et al. (2018) Predisposing germline mutations in young patients with squamous cell cancer of the oral cavity. JCO Precis. Oncol. 2, 1-8.
<https://doi.org/10.1200/PO.18.00022>
34. , W. D., Brunet, J. S., Kowalski, L. P. et al. (1995) Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int. J. Cancer 63, 769-773.
<https://doi.org/10.1002/ijc.2910630603>
35. , T., Bajalica Lagercrantz, S., Oliveira, C. et al. (2020) Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. Eur. J. Hum. Genet. 28, 1379-1386.
<https://doi.org/10.1038/s41431-020-0638-4>
36. , J. D., Limagne, E., Thibaudin, M. et al. (2020) Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment. BMC Cancer 20, 748.
<https://doi.org/10.1186/s12885-020-07253-x>
37. , M. A., Zhang, J., Shen, L. et al. (2017) CDKN2A/p16 deletion in head and neck cancer cells is associated with CDK2 activation, replication stress, and vulnerability to CHK1 inhibition. Cancer Res. 78, 781-797.
<https://doi.org/10.1158/0008-5472.CAN-17-2802>
38. , T., Hammel, P., Reni, M. et al. (2019) Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N. Engl. J. Med. 381, 317-327.
<https://doi.org/10.1056/NEJMoa1903387>
39. , T., Malkin, D. (2017) Inherited TP53 mutations and the Li-Fraumeni syndrome. Cold Spring Harb. Perspect. Med. 7, a026187.
<https://doi.org/10.1101/cshperspect.a026187>
40. , J., Iftner, T. (2013) Human papillomaviruses and cancer. Radiother. Oncol. 108, 397-402.
<https://doi.org/10.1016/j.radonc.2013.06.004>
41. , Y. Q., Wang, T. M., Ji, M. et al. (2022) A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening. Nat. Commun. 13, 1966.
<https://doi.org/10.1038/s41467-022-29570-4>
42. , M., Kleiblová, P., Nehasil, P. et al. (2023) Polygenic risk score (PRS) and its potential for breast cancer risk stratification. Klin. Onkol. 36, 198-205.
<https://doi.org/10.48095/ccko2023198>
43. Institute of Health Information and Statistics of the Czech Republic (2019) Národní onkologický registr (NOR) (National Cancer Registry), [cit. 28. 11. 2019]. Available at: http://www.uzis.cz/registry-nzis/nor (in Czech)
44. , A. R., Forbes, K., Orosco, R. K. et al. (2022) Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report. J. Otolaryngol. Head Neck Surg. 51, 5.
<https://doi.org/10.1186/s40463-022-00556-y>
45. , X., Zhang, W., Xie, C. et al. (2011) Nasopharyngeal carcinoma risk by histologic type in central China: impact of smoking, alcohol and family history. Int. J. Cancer 129, 724-732.
<https://doi.org/10.1002/ijc.25696>
46. , W. H., Feng, B. J., Xu, Z. L. et al. (2004) Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer 101, 363-369.
<https://doi.org/10.1002/cncr.20372>
47. , B., Ertan, K., Düzova, M. et al. (2022) Familial clustering of nasopharyngeal carcinoma in the family of an adolescent with nasopharyngeal carcinoma. Turk. J. Pediatr. 64, 1130-1135.
<https://doi.org/10.24953/turkjped.2022.62>
48. , G., Ison, G., McKee, A. E. et al. (2015) FDA approval summary: olaparib monotherapy in patients with deleterious germline BRCA-mutated advanced ovarian cancer treated with three or more lines of chemotherapy. Clin. Cancer Res. 21, 4257-4261.
<https://doi.org/10.1158/1078-0432.CCR-15-0887>
49. , N., Hara, T., Tamae, A. et al. (2010) A case of laryngeal carcinoma in a young adult with dyskeratosis congenita. Int. J. Clin. Oncol. 15, 428-432.
<https://doi.org/10.1007/s10147-010-0053-x>
50. , T., Yamazaki, F., Nakano, Y. et al. (2021) Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1. Int. J. Clin. Oncol. 26, 2161-2178.
<https://doi.org/10.1007/s10147-021-02011-w>
51. , A. K., Barankin, B., Lam, J. M. et al. (2022) Xeroderma pigmentosum: an updated review. Drugs Context 11, 2022-2-5.
52. , F., Norell, S. E., Johansson, H. (1998) Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 82, 1367-1375.
<https://doi.org/10.1002/(SICI)1097-0142(19980401)82:7<1367::AID-CNCR21>3.0.CO;2-3>
53. , Q. C., Fang, Y., Li, X. Y. et al. (2007) Loss of heterozygosity in the region of chromosome 4p15.14q12 in nasopharyngeal carcinoma patients with familial history. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24, 189-191. (in Chinese)
54. , R., Pechačová, Z., Mazaná, E. et al. (2022) Radiotherapy and radiosensitivity syndromes in DNA repair gene mutations. Klin. Onkol. 35, 119-127.
55. , H. T., Shaw, T. G. (2016) Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity. Fam. Cancer 15, 487-491.
<https://doi.org/10.1007/s10689-016-9888-2>
56. , S., Sah, R., Muhammad, K. et al. (2023) Tracking HPV infection, associated cancer development, and recent treatment efforts – a comprehensive review. Vaccines (Basel) 11, 102.
<https://doi.org/10.3390/vaccines11010102>
57. , A., Risitano, A. M., Copelli, C. et al. (2021) Dyskeratosis congenita and squamous cell carcinoma of the mandibular alveolar ridge. BMJ Case Rep. 14, e242459.
<https://doi.org/10.1136/bcr-2021-242459>
58. , A., Le, D. T., Ascierto, P. A. et al. (2019) Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J. Clin. Oncol. 38, 1-10.
<https://doi.org/10.1200/JCO.19.02105>
59. , T. (2022) Involvement of the p53-p16/RB pathway control mechanism in early-stage carcinogenesis in head and neck squamous cell carcinoma. Pathol. Int. 72, 577-588.
<https://doi.org/10.1111/pin.13279>
60. , E., Boffetta, P., Berthiller, J. et al. (2009) Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int. J. Cancer 124, 394-401.
<https://doi.org/10.1002/ijc.23848>
61. , V., Lazar, A. J. (2022) Update from the 5th Edition of the World Health Organization classification of head and neck tumors: familial tumor syndromes. Head Neck Pathol. 16, 143-157.
<https://doi.org/10.1007/s12105-022-01414-z>
62. , B., Huang, S. H., Su, J. et al. (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 17, 440-451.
<https://doi.org/10.1016/S1470-2045(15)00560-4>
63. , S. S., Thakker, N. S., Pring, M. et al. (2001) A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma. Oral Oncol. 37, 1-16.
<https://doi.org/10.1016/S1368-8375(00)00055-5>
64. , E., Ledermann, J. A., Selle, F. et al. (2017) Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 18, 1274-1284.
<https://doi.org/10.1016/S1470-2045(17)30469-2>
65. , N. (2014) Realizing the promise of cancer predisposition genes. Nature 505, 302-308.
<https://doi.org/10.1038/nature12981>
66. , E. R. H., DiGiovanna, J. J., Khan, S. G. et al. (2021) Xeroderma pigmentosum: a model for human premature aging. J. Invest. Dermatol. 141, 976-984.
<https://doi.org/10.1016/j.jid.2020.11.012>
67. , M. E., Tung, N., Conte, P. et al. (2019) OlympiAD final overall survival and tolerability results: olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer. Ann. Oncol. 30, 558-566.
<https://doi.org/10.1093/annonc/mdz012>
68. , K. D., Schneider, K. W., Suttman, A. et al. (2021) Pediatric head and neck tumors associated with Li-Fraumeni syndrome. Ann. Otol. Rhinol. Laryngol. 10, 34894211014786.
69. , K., Wagenmann, M., Freund, M. et al. (2012) Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines. Klin. Padiatr. 224, 132-138.
70. , O. D. (2013) Nucleotide excision repair in eukaryotes. Cold Spring Harb. Perspect. Biol. 5, a012609.
<https://doi.org/10.1101/cshperspect.a012609>
71. , S., Findikcioglu, K., Erdal, A. I. et al. (2016) Technical aspects and difficulties in the management of head and neck cutaneous malignancies in xeroderma pigmentosum. Arch. Plast. Surg. 43, 344-351.
72. , Z. K., Maio, A., Chakravarty, D. et al. (2021) Therapeutic implications of germline testing in patients with advanced cancers. J. Clin. Oncol. 39, 2698-2709.
<https://doi.org/10.1200/JCO.20.03661>
73. , H., Ferlay, J., Siegel, R. L. et al. (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209-249.
<https://doi.org/10.3322/caac.21660>
74. , A., Weinel, S., Nagy, N. et al. (2012) Germline mutation in ATR in autosomal-dominant oropharyngeal cancer syndrome. Am. J. Hum. Genet. 90, 511-517.
<https://doi.org/10.1016/j.ajhg.2012.01.007>
75. , M., Lautenberger, J. A., Gao, X. et al. (2012) The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet. 8, e1003103.
<https://doi.org/10.1371/journal.pgen.1003103>
76. , J. G., Bamford, S., Jubb, H. C. et al. (2019) COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 8, D941-D947.
<https://doi.org/10.1093/nar/gky1015>
77. , K. P., Su, W. H., Chang, K. P. et al. (2009) Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am. J. Hum. Genet. 85, 194-203.
<https://doi.org/10.1016/j.ajhg.2009.07.007>
78. , A., Chen, C. J., Levine, P. H. et al. (1999) Familial and sporadic cases of nasopharyngeal carcinoma in Taiwan. Anticancer Res. 19, 661-665.
79. , P. M., Noorlag, R., Braunius, W. W. et al. (2015) Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma. Cancer Med. 4, 1525-1535.
<https://doi.org/10.1002/cam4.499>
80. , E., Dietrich, R. (2014) Fanconi anemia: young patients at high risk for squamous cell carcinoma. Mol. Cell. Pediatr. 1, 9.
<https://doi.org/10.1186/s40348-014-0009-8>
81. , E. E., Agrawal, N., Seiwert, T. Y. (2015) HPV-associated head and neck cancer. J. Natl. Cancer Inst. 107, 344.
<https://doi.org/10.1093/jnci/djv344>
82. , T. M., Zhou, T., He, Y. Q. et al. (2018) Fine-mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility. Cancer Med. 7, 6308-6316.
<https://doi.org/10.1002/cam4.1838>
83. , S. A. Jr., Robinson, B. G., Gagel, R. F. et al. (2012) Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J. Clin. Oncol. 30, 134-141.
<https://doi.org/10.1200/JCO.2011.35.5040>
84. World Health Organization (2022) WHO Classification of Tumours Editorial Board. Head and Neck Tumours. Lyon (France): International Agency for Research on Cancer; 2022. (WHO Classification of Tumours Series, 5th ed.; vol. 9). Available at: https://publications.iarc.fr/
85. , L. J., Sherman, E., Robinson, B. et al. (2020) Efficacy of selpercatinib in RET-altered thyroid cancers. N. Engl. J. Med. 383, 825-835.
<https://doi.org/10.1056/NEJMoa2005651>
86. , A., Hashibe, M., Chuang, S. C. (2013) Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am. J. Epidemiol. 178, 679-690.
<https://doi.org/10.1093/aje/kwt029>
87. , H., Yin, X., Mao, Y. et al. (2022) The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019. Eur. Arch. Otorhinolaryngol. 279, 1519-1533.
<https://doi.org/10.1007/s00405-021-06922-2>
88. , Z., Zhou, Y., Zhang, W. et al. (2006) Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet. Med. 8, 156-160.
<https://doi.org/10.1097/01.gim.0000196821.87655.d0>
